Dr. Reddy's Laboratories launches Amlodipine Besylate and Atorvastatin Calcium Tablets

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Mar 27 2014Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10mg, 2.5/20mg, 2.5/40mg, 5/10mg, 5/20mg, 5/40mg, 5/80mg, 10/10mg, 10/20mg, 10/40mg and 10/80 mg a therapeutic equivalent generic version of CADUET® (amlodipine Besylate and atorvastatin calcium) tablets, in the US market on March 26, 2014, following the approval by the United States Food & Drug Administration (USFDA).

The CADUET® tablets brand and generic had U.S. sales of approximately $163 Million MAT for the most recent twelve months ending in January 2014 according to IMS Health*.

Dr. Reddy's Amlodipine Besylate and Atorvastatin Calcium Tablets are available in bottle counts of 30 and 90**.

Source:

Dr. Reddy's Laboratories Ltd.

Posted in: Pharmaceutical News

Tags: , , , , ,

Comments (0)

Suggested Reading

Calcium crystal deposits linked to worsening knee osteoarthritis, study finds
Balancing diets: study reveals plant protein's impact on nutrient levels in Americans
Coronary artery calcium scoring with CT can predict risk of heart attacks or strokes
The relationship between calcium consumption at various times of the day and cardiovascular disease
Astrocytes found to play pivotal role in epileptic neuronal hyperactivity
Vitamin D deficiency persists despite easy access, review suggests need for tailored supplements
Study reveals novel approach to promote efficient uptake of ASOs into cancer cells
Cardiovascular risk can rise sharply after women go through menopause

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Link between nutrient intake and multimorbidity risk reported in recent study, more research is needed